Krish Patel

Krish Patel

Sarah Cannon Research Institute - / United States
Others
AD Scientific Index ID: 4969518
person_outline Krish Patel's MOST POPULAR ARTICLES
1-) Outcomes of COVID-19 in patients with CLL: a multicenter international experience Blood, The Journal of the American Society of Hematology 136 (10), 1134-1143, 2020
2-) Use of convalescent plasma in hospitalized patients with COVID-19: case series Blood, The Journal of the American Society of Hematology 136 (6), 759-762, 2020
3-) Pirtobrutinib in covalent Bruton tyrosine kinase inhibitor pretreated mantle-cell lymphoma Journal of Clinical Oncology 41 (24), 3988-3997, 2023
4-) NX-2127-001, a first-in-human trial of NX-2127, a Bruton's tyrosine kinase-targeted protein degrader, in patients with relapsed or refractory chronic lymphocytic leukemia and B … Blood 140 (Supplement 1), 2329-2332, 2022
5-) Safety and efficacy of FT596, a first-in-class, multi-antigen targeted, off-the-shelf, iPSC-derived CD19 CAR NK cell therapy in relapsed/refractory B-cell lymphoma Blood 138, 823, 2021